Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

A specific group of early-stage melanocytes is reduced in vitiligo-affected skin, which may explain treatment resistance.

High glycine–tyrosine keratin-associated proteins help make hair strong and maintain its shape.

Green tea compound EGCG may help hair growth by boosting cell activity.

Keratin 19 expression in certain skin cells is temporary and not a reliable stem cell marker.

Hair follicle dermal stem cells are key for regenerating parts of the hair follicle and determining hair type.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Lymphocytes, a type of immune cell, are crucial for wound healing as they help remodel damaged areas and reduce inflammation.

Dsg1 is essential for maintaining a healthy skin barrier in mice.

Canine hair follicles contain stem-like cells with high growth potential.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

A3 antibody helps identify key cells in rat hair follicle development.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

The US and EU lead in cell and gene therapy regulations with more approvals and clinical trials, while India is in early stages with fewer approvals and expedited processes.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

Stem cells from diabetic mice can still help heal wounds effectively.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

DSC cell injections significantly improved hair density and diameter, showing potential as a hair loss treatment.